Viridian Therapeutics
VRDN
VRDN
6 hedge funds and large institutions have $626K invested in Viridian Therapeutics in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HA
1
Heartland Advisors
Milwaukee,
Wisconsin
|
$487K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$7K |
| 3 |
3
Citigroup
New York
|
$1K |
Top Sellers
| 1 |
PCM
1
Perkins Capital Management
Wayzata,
Minnesota
|
$126K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$5K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HA
1
Heartland Advisors
Milwaukee,
Wisconsin
| $487K | 191,700 | +11,700 | +7% |
|
|
PCM
2
Perkins Capital Management
Wayzata,
Minnesota
| $126K | 49,800 | -13,500 | -21% |
|
|
3
UBS Group
Zurich,
Switzerland
| $7K | 2,655 | +2,655 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $5K | 2,002 | -30 | -1% |
|
|
5
Citigroup
New York
| $1K | 500 | +500 | New |
|
6
Morgan Stanley
New York
| $0 | 6 | – | – |
|